This strengthens Google’s position against rivals such as Microsoft and AWS as enterprises seek faster, more reliable ways to ...
The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.
Kapiva is currently operating at an annual revenue run rate (ARR) of Rs 550 crore, up from Rs 350 crore in FY25, reflecting strong consumer adoption across categories and channels Bengaluru-based ...
With the business potentially at an important milestone, we thought we'd take a closer look at Vertex, Inc.'s (NASDAQ:VERX) future prospects. Vertex, Inc., together with its subsidiaries, provides ...
Rajeev Dhir is a writer with 10+ years of experience as a journalist with a background in broadcast, print, and digital newsrooms. SEC Form 3: Initial Statement of Beneficial Ownership of Securities ...
This story appeared in Esquire's About Time newsletter. Get it free into your inbox every Sunday at 8am. Sign up here You can find the Vertex Watch Company tucked among the narrow cobbled streets, ...
Vertex Inc. reported its second-quarter earnings for 2025, showcasing a modest earnings beat with an EPS of $0.15 compared to the forecasted $0.14. The revenue aligned with expectations at $184.6 ...
After the FDA's landmark approval of the opioid-free acute pain reliever Journavx in January, Vertex Pharmaceuticals has hit a snag on its path to expand the potential blockbuster’s reach into ...
Vertex Pharmaceuticals Incorporated VRTX stock has declined 8.9% in the past three months. The deterioration was due to soft first-quarter results, slower-than-expected uptake of its newer drugs as ...
Vertex Pharmaceuticals, a US-based drugmaker known for transformative therapies, is developing a new treatment called Zimislecel (formerly VX-880) that could revolutionize how Type 1 Diabetes (T1D) is ...
MCLEAN, Va. - V2X, Inc. (NYSE:VVX), a prominent provider of global mission solutions with annual revenue of $4.3 billion and market capitalization of $1.6 billion, disclosed today that Vertex ...